The classification is based on a composite score that examines a wide range of fundamental and technical measures. +0.11 (+0.15%) DATA AS OF Feb 26, 2021. Share Name Share Symbol Market Type; Simulations Plus Inc: NASDAQ:SLP: NASDAQ: Common Stock Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 0.00: 0.0%: 32.83: 33.06: 34.00: 0.00: article's content and its accuracy. View Simulations Plus stock / share price, financial statements, key ratios and more at Craft. Get the latest insider transactions for Simulations Plus, Inc. (SLP). Covid-19 has shaken world markets and a question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect mid-cap shares like Simulations Plus Inc (NAQ:SLP)... Quality and momentum are highly prized among investors looking for reliable investment ideas. Shares in Simulations Plus Inc are currently priced at $66.46. Box 1342 Brentwood, NY 11717 Phone: 800-733-1121 E-mail Whistleblower Hotline (661) 941-4200 The selling price currently displayed is higher than the buying price. Data is currently not available. Simulations Plus market cap is $1.5 b, and annual revenue was $33.97 m in FY 2019. The shares are currently trading at $66.46. Name: Simulations Plus, Inc. Ticker: SLP; Exchange: NasdaqCM; Founded: 1996; Industry: Health Care Technology; Sector: Healthcare; Market Cap: US$1.458b; Shares outstanding: 19.96m; Website: https://www.simulations-plus.com Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. investments are right for you, please request advice, for example from our, Register for online Try our handy filter to explore the different options. Coronavirus - we're here to help Simulations Plus Inc is scheduled to issue upcoming financial results on the following dates: The Simulations Plus Inc dividend yield is 0.36% based on the trailing twelve month period. Hargreaves Lansdown is not responsible for an are trading at To buy shares in , you'll need to have an account. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Buying shares in the best businesses can build meaningful wealth for you and your family. Simulations Plus Inc. company facts, information and financial ratios from MarketWatch. The all-time high Simulations Plus stock closing price was 89.52 on February 09, 2021 . Nasdaq 100. Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries.In September 2014, the company acquired Cognigen Corporation, a leading provider of clinical trial data analysis and consulting services. It is calculated by dividing a company's price per share by its earnings per share. Shares in Simulations Plus Inc are currently trading at $66.46, giving the company a market capitalisation of £958.6m. The historic dividend yield on Simulations Plus Inc shares is currently 0.36%. and the price has moved by wellbeing and our community we're So in general terms, the higher the PE, the more expensive the stock is. To try and predict where the Simulat... Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. Find the latest Simulations Plus, Inc. (SLP) stock quote, history, news and other vital information to help you with your stock trading and investing. The Simulations Plus Inc (NAQ:SLP) share price is currently trading at 72.09. To buy shares in Simulations Plus Inc you'll need a share-dealing account with an online or offline stock broker. To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. Our analysts have selected this fund for the Wealth Shortlist. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. Revenues reflect Lancastersegment increase of 10% to $5.4M, Buffalo segment increaseof 12% to $2.7M, Europe segment increase of 68% to $2.5M.Net income benefited from Lancaster segment income increaseof 24% to $2.4M, Buffalo segment income increase from $40Kto $206K. Transfer Agent & Registrar Broadridge Corporate Issuer Solutions P.O. But given the volatile market conditions and uncertain economic outlook, the question now is what the future holds for it. Shares in Simulations Plus Inc are currently trading at Its pharmaceutical/chemistry software is used by various companies, such as pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies for use in the conduct of industry-based research. You can view the full broker recommendation list by unlocking its StockReport. You can read more about the power of momentum in assessing share price movements on Stockopedia. Dividend information for this stock is not available. Of the analysts with advisory recommendations for Simulations Plus Inc, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. 96.22% over the past 365 days. Price to Earnings Ratio vs. the Market The P/E ratio of Simulations Plus is 130.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 31.94. Simulations Plus is selling at 72.28 as of the 19th of October 2020; that is 0.53 percent increase since the beginning of the trading day. The latest Simulations Plus Inc Com USD0.001 share price. Dividend per share remained flat at $0.06. We may not share Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for... [UK] Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. But to assess whether the price is likely to fall or rally over the next 12 months, we need an objective way of telling whether it's able to withstand economic shocks and ride out market volatility. * To buy US shares you must first complete and return a US government, Our website offers information about investing and saving, but not personal advice. Simulations Plus market cap as of February 19, 2021 is $1.51B. Netincome increased 20% to $2.5M. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives. 42505 10th St W, LANCASTER, 93534-7059, United States, BRIEF-Simulations Plus Enters Agreement With Distributor In China, BRIEF-Simulations Plus Enters New Funded Collaboration To Improve Lung Exposure Models For Pulmonary Infection Treatments, BRIEF-Simulations Plus Reports Q1 Earnings Per Share $0.12, BRIEF-Simulations Plus Names Industry Veteran Will Frederick As Chief Financial Officer, BRIEF-Simulations Plus Reports Q4 Earnings Per Share Of $0.11. Shares in Simulations Plus Inc are currently trading at 71.5. $66.46 Simulations Plus Inc. () Stock Market info Recommendations: Buy or sell Simulations Plus stock? The stock's last reported lowest price was 71.78. Its clinical-pharmacology-based consulting services include pharmacokinetic and pharmacodynamics modeling, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions. The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed.